Demographics (1)
- Age - Age of participant (phv00292638.v1.p1)
Disease Events (4)
- ER - Estrogen receptor status (phv00292635.v1.p1)
- HER2 - HER2 status (phv00292637.v1.p1)
- Histology - Tumor histology (phv00292639.v1.p1)
- PR - Progesterone receptor status (phv00292636.v1.p1)
Race and Ethnicity (1)
- Ethnicity - Ethnicity of participant (phv00292640.v1.p1)
Other (11)
- ANALYTE_Type - Molecular analyte (phv00292644.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00292629.v1.p1)
- SAMPID - De-identified Sample ID (phv00292641.v1.p1)
- SAMPID - Sample ID (phv00292631.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00292642.v1.p1)
- SAMPLE_USE - Use of samples. Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_Target: Custom targeted DNA sequencing (phv00292632.v1.p1)
- SUBJID - Unique Participant Identifier (phv00292633.v1.p1)
- SUBJID - Subject ID (phv00292630.v1.p1)
- SUBJID - Subject ID (phv00292628.v1.p1)
- Tumor in normal contamination - Contamination of normal with matched tumor (phv00292634.v1.p1)
- Tumor Type - Indicates primary or secondary tumor (phv00292643.v1.p1)